Get 50% OFF This Monsoon!
Archit Organosys
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
=Archit Organosys Limited is a public company incorporated in 04th August 1993. The Company is mainly engaged in the business of manufacturing and trading of various chemical products.
During the year 2016-17, the Board of Directors of the Company at its meeting held on 24 March 2017 allotted 1,00,42,200 partly paid equity shares having face value of Rs. 10/- each at a price of Rs. 25/- per share (including premium of Rs.15/-). Rs 12.50 has been received by Company on application and remaining amount be payable on first and final call as and when the same is made. The Company received the listing and trading approval for said shares from BSE Limited and the shares of the Company are traded on stock exchange from 05 April 2017.
During the year 2017-18, the Board called up the first and final call money of Rs. 12.50 each (Rs. 5 towards face value and Rs. 7.50 towards securities premium account). The Company received the amount towards first and final call money for 99,99,623 partly paid equity shares. The same has been converted into fully paid up and are listed and traded under ISIN of fully paid up shares on BSE Limited.
During the year 2017-18, balance 42,577partly paid up equity shares on which the first and final call money has not been received within one year from the date of allotment were forfeited by Board in due compliance of provision of Articles of Association of the Company and the Companies Act, 2013.
Archit Organosys share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Archit Organosys indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Archit Organosys is valued compared to its competitors.
Archit Organosys PE ratio helps investors understand what is the market value of each stock compared to Archit Organosys 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Archit Organosys evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Archit Organosys generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Archit Organosys in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Archit Organosys shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Archit Organosys compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Archit Organosys over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Archit Organosys helps investors get an insight into when they can enter or exit the stock. Key components of Archit Organosys Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Archit Organosys shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Archit Organosys ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Archit Organosys provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Archit Organosys highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Archit Organosys .
The balance sheet presents a snapshot of Archit Organosys ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.